Industry Research Reports
Home > Reports > Pharma & Healthcare > Paliperidone Palmitate Long-Acting Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Paliperidone Palmitate Long-Acting Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Paliperidone Palmitate Long-Acting Injection Market Size(US$)
CAGR 2026-2032
6.3%
Market Size,2032
USD 6,640
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 4,602 million
Market Forecast in 2032(Value)
US$ 6,640 million
CAGR
6.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4355 million in 2025 and is projected to reach US$ 6640 million, growing at a CAGR of 6.3% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Paliperidone Palmitate Long-Acting Injection cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Paliperidone palmitate long-acting injection is a sustained-release antipsychotic injection, the main ingredient of which is paliperidone palmitate, a long-acting esterified form of paliperidone. The preparation is administered by intramuscular injection and can gradually hydrolyze and release active drugs in the body to achieve a sustained therapeutic effect. It is usually injected once a month for the treatment of schizophrenia and related mental disorders, which helps to improve patient compliance, reduce the risk of relapse and improve treatment stability.
The North American market for Paliperidone Palmitate Long-Acting Injection was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Paliperidone Palmitate Long-Acting Injection was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Paliperidone Palmitate Long-Acting Injection was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Paliperidone Palmitate Long-Acting Injection market include Janssen Pharmaceuticals, Teva Pharmaceutical, Viatris, Sun Pharmaceutical, Cipla, Hikma Pharmaceuticals, Qilu Pharmaceutical, Hansoh Pharmaceuticak Group, Luye Pharma Group, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Paliperidone Palmitate Long-Acting Injection, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Paliperidone Palmitate Long-Acting Injection market size, estimations, and forecasts are presented in terms of sales volume (K Dose) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Paliperidone Palmitate Long-Acting Injection.
Market Segmentation
By Company
- Janssen Pharmaceuticals
- Teva Pharmaceutical
- Viatris
- Sun Pharmaceutical
- Cipla
- Hikma Pharmaceuticals
- Qilu Pharmaceutical
- Hansoh Pharmaceuticak Group
- Luye Pharma Group
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Monthly Dosage Form
- Quarterly Dosage Form
Segment by Application
- General Hospital
- Specialized Hospital
- Others
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Paliperidone Palmitate Long-Acting Injection manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Paliperidone Palmitate Long-Acting Injection sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Paliperidone Palmitate Long-Acting Injection sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 Paliperidone Palmitate Long-Acting Injection Product Introduction
1.2 Global Paliperidone Palmitate Long-Acting Injection Market Size Forecast
1.2.1 Global Paliperidone Palmitate Long-Acting Injection Sales Value (2021–2032)
1.2.2 Global Paliperidone Palmitate Long-Acting Injection Sales Volume (2021–2032)
1.2.3 Global Paliperidone Palmitate Long-Acting Injection Sales Price (2021–2032)
1.3 Paliperidone Palmitate Long-Acting Injection Market Trends & Drivers
1.3.1 Paliperidone Palmitate Long-Acting Injection Industry Trends
1.3.2 Paliperidone Palmitate Long-Acting Injection Market Drivers & Opportunities
1.3.3 Paliperidone Palmitate Long-Acting Injection Market Challenges
1.3.4 Paliperidone Palmitate Long-Acting Injection Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Paliperidone Palmitate Long-Acting Injection Players Revenue Ranking (2025)
2.2 Global Paliperidone Palmitate Long-Acting Injection Revenue by Company (2021–2026)
2.3 Global Paliperidone Palmitate Long-Acting Injection Sales Volume Ranking of Players (2025)
2.4 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Company (2021–2026)
2.5 Global Paliperidone Palmitate Long-Acting Injection Average Price by Company (2021–2026)
2.6 Key Manufacturers Paliperidone Palmitate Long-Acting Injection Manufacturing Base and Headquarters
2.7 Key Manufacturers Paliperidone Palmitate Long-Acting Injection Product Offerings
2.8 Key Manufacturers Start of Mass Production of Paliperidone Palmitate Long-Acting Injection
2.9 Paliperidone Palmitate Long-Acting Injection Market Competitive Analysis
2.9.1 Paliperidone Palmitate Long-Acting Injection Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Paliperidone Palmitate Long-Acting Injection Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Paliperidone Palmitate Long-Acting Injection revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Paliperidone Palmitate Long-Acting Injection Market Classification
3.1 Introduction by Type
3.1.1 Monthly Dosage Form
3.1.2 Quarterly Dosage Form
3.1.3 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Type
3.1.3.1 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Paliperidone Palmitate Long-Acting Injection Sales Value, by Type (2021–2032)
3.1.3.3 Global Paliperidone Palmitate Long-Acting Injection Sales Value, by Type (%), 2021–2032
3.1.4 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Type
3.1.4.1 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Paliperidone Palmitate Long-Acting Injection Sales Volume, by Type (2021–2032)
3.1.4.3 Global Paliperidone Palmitate Long-Acting Injection Sales Volume, by Type (%), 2021–2032
3.1.5 Global Paliperidone Palmitate Long-Acting Injection Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 General Hospital
4.1.2 Specialized Hospital
4.1.3 Others
4.2 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Application
4.2.1 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Paliperidone Palmitate Long-Acting Injection Sales Value, by Application (2021–2032)
4.2.3 Global Paliperidone Palmitate Long-Acting Injection Sales Value, by Application (%), 2021–2032
4.3 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Application
4.3.1 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Paliperidone Palmitate Long-Acting Injection Sales Volume, by Application (2021–2032)
4.3.3 Global Paliperidone Palmitate Long-Acting Injection Sales Volume, by Application (%), 2021–2032
4.4 Global Paliperidone Palmitate Long-Acting Injection Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region
5.1.1 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (2021–2026)
5.1.3 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (2027–2032)
5.1.4 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (%), 2021–2032
5.2 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region
5.2.1 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (2021–2026)
5.2.3 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (2027–2032)
5.2.4 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (%), 2021–2032
5.3 Global Paliperidone Palmitate Long-Acting Injection Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
5.4.2 North America Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
5.5.2 Europe Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
5.6.2 Asia Pacific Paliperidone Palmitate Long-Acting Injection Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
5.7.2 South America Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
5.8.2 Middle East & Africa Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value and Sales Volume
6.2.1 Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
6.2.2 Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
6.3.2 United States Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
6.4.2 Europe Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
6.5.2 China Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
6.5.3 China Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
6.6.2 Japan Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
6.7.2 South Korea Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
6.8.2 Southeast Asia Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Paliperidone Palmitate Long-Acting Injection Sales Value, 2021–2032
6.9.2 India Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
6.9.3 India Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Janssen Pharmaceuticals
7.1.1 Janssen Pharmaceuticals Company Information
7.1.2 Janssen Pharmaceuticals Introduction and Business Overview
7.1.3 Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product Offerings
7.1.5 Janssen Pharmaceuticals Recent Developments
7.2 Teva Pharmaceutical
7.2.1 Teva Pharmaceutical Company Information
7.2.2 Teva Pharmaceutical Introduction and Business Overview
7.2.3 Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Offerings
7.2.5 Teva Pharmaceutical Recent Developments
7.3 Viatris
7.3.1 Viatris Company Information
7.3.2 Viatris Introduction and Business Overview
7.3.3 Viatris Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Viatris Paliperidone Palmitate Long-Acting Injection Product Offerings
7.3.5 Viatris Recent Developments
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Information
7.4.2 Sun Pharmaceutical Introduction and Business Overview
7.4.3 Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Offerings
7.4.5 Sun Pharmaceutical Recent Developments
7.5 Cipla
7.5.1 Cipla Company Information
7.5.2 Cipla Introduction and Business Overview
7.5.3 Cipla Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Cipla Paliperidone Palmitate Long-Acting Injection Product Offerings
7.5.5 Cipla Recent Developments
7.6 Hikma Pharmaceuticals
7.6.1 Hikma Pharmaceuticals Company Information
7.6.2 Hikma Pharmaceuticals Introduction and Business Overview
7.6.3 Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product Offerings
7.6.5 Hikma Pharmaceuticals Recent Developments
7.7 Qilu Pharmaceutical
7.7.1 Qilu Pharmaceutical Company Information
7.7.2 Qilu Pharmaceutical Introduction and Business Overview
7.7.3 Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Offerings
7.7.5 Qilu Pharmaceutical Recent Developments
7.8 Hansoh Pharmaceuticak Group
7.8.1 Hansoh Pharmaceuticak Group Company Information
7.8.2 Hansoh Pharmaceuticak Group Introduction and Business Overview
7.8.3 Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Product Offerings
7.8.5 Hansoh Pharmaceuticak Group Recent Developments
7.9 Luye Pharma Group
7.9.1 Luye Pharma Group Company Information
7.9.2 Luye Pharma Group Introduction and Business Overview
7.9.3 Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Product Offerings
7.9.5 Luye Pharma Group Recent Developments
8 Industry Chain Analysis
8.1 Paliperidone Palmitate Long-Acting Injection Industrial Chain
8.2 Paliperidone Palmitate Long-Acting Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Paliperidone Palmitate Long-Acting Injection Sales Model
8.5.2 Sales Channels
8.5.3 Paliperidone Palmitate Long-Acting Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Paliperidone Palmitate Long-Acting Injection Market Trends
Table 2. Paliperidone Palmitate Long-Acting Injection Market Drivers & Opportunities
Table 3. Paliperidone Palmitate Long-Acting Injection Market Challenges
Table 4. Paliperidone Palmitate Long-Acting Injection Market Restraints
Table 5. Global Paliperidone Palmitate Long-Acting Injection Revenue by Company (US$ Million), 2021–2026
Table 6. Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Company (2021–2026)
Table 7. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Company (K Dose), 2021–2026
Table 8. Global Paliperidone Palmitate Long-Acting Injection Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Paliperidone Palmitate Long-Acting Injection Price by Company (US$/Dose), 2021–2026
Table 10. Key Manufacturers Paliperidone Palmitate Long-Acting Injection Manufacturing Base and Headquarters
Table 11. Key Manufacturers Paliperidone Palmitate Long-Acting Injection Product Type
Table 12. Key Manufacturers Start of Mass Production of Paliperidone Palmitate Long-Acting Injection
Table 13. Global Paliperidone Palmitate Long-Acting Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Paliperidone Palmitate Long-Acting Injection revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Value by Type (2021–2026)
Table 20. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Value by Type (2027–2032)
Table 21. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Type: 2021 vs 2025 vs 2032 (K Dose)
Table 22. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Type (K Dose), 2021–2026
Table 23. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Type (K Dose), 2027–2032
Table 24. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Paliperidone Palmitate Long-Acting Injection Price by Type (US$/Dose), 2021–2026
Table 27. Global Paliperidone Palmitate Long-Acting Injection Price by Type (US$/Dose), 2027–2032
Table 28. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Value by Application (2021–2026)
Table 32. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Value by Application (2027–2032)
Table 33. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Application: 2021 vs 2025 vs 2032 (K Dose)
Table 34. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Application (K Dose), 2021–2026
Table 35. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Application (K Dose), 2027–2032
Table 36. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Paliperidone Palmitate Long-Acting Injection Price by Application (US$/Dose), 2021–2026
Table 39. Global Paliperidone Palmitate Long-Acting Injection Price by Application (US$/Dose), 2027–2032
Table 40. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (%), 2021–2026
Table 44. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (%), 2027–2032
Table 45. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (K Dose): 2021 vs 2025 vs 2032
Table 46. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (K Dose), 2021–2026
Table 47. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (K Dose), 2027–2032
Table 48. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (%), 2021–2026
Table 49. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (%), 2027–2032
Table 50. Global Paliperidone Palmitate Long-Acting Injection Average Price by Region (US$/Dose), 2021–2026
Table 51. Global Paliperidone Palmitate Long-Acting Injection Average Price by Region (US$/Dose), 2027–2032
Table 52. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Volume, (K Dose), 2021–2026
Table 56. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Volume, (K Dose), 2027–2032
Table 57. Janssen Pharmaceuticals Company Information
Table 58. Janssen Pharmaceuticals Introduction and Business Overview
Table 59. Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
Table 60. Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 61. Janssen Pharmaceuticals Recent Developments
Table 62. Teva Pharmaceutical Company Information
Table 63. Teva Pharmaceutical Introduction and Business Overview
Table 64. Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
Table 65. Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 66. Teva Pharmaceutical Recent Developments
Table 67. Viatris Company Information
Table 68. Viatris Introduction and Business Overview
Table 69. Viatris Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
Table 70. Viatris Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 71. Viatris Recent Developments
Table 72. Sun Pharmaceutical Company Information
Table 73. Sun Pharmaceutical Introduction and Business Overview
Table 74. Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
Table 75. Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 76. Sun Pharmaceutical Recent Developments
Table 77. Cipla Company Information
Table 78. Cipla Introduction and Business Overview
Table 79. Cipla Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
Table 80. Cipla Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 81. Cipla Recent Developments
Table 82. Hikma Pharmaceuticals Company Information
Table 83. Hikma Pharmaceuticals Introduction and Business Overview
Table 84. Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
Table 85. Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 86. Hikma Pharmaceuticals Recent Developments
Table 87. Qilu Pharmaceutical Company Information
Table 88. Qilu Pharmaceutical Introduction and Business Overview
Table 89. Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
Table 90. Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 91. Qilu Pharmaceutical Recent Developments
Table 92. Hansoh Pharmaceuticak Group Company Information
Table 93. Hansoh Pharmaceuticak Group Introduction and Business Overview
Table 94. Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
Table 95. Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 96. Hansoh Pharmaceuticak Group Recent Developments
Table 97. Luye Pharma Group Company Information
Table 98. Luye Pharma Group Introduction and Business Overview
Table 99. Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021–2026)
Table 100. Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 101. Luye Pharma Group Recent Developments
Table 102. Key Raw Materials Lists
Table 103. Key Suppliers of Raw Materials Lists
Table 104. Paliperidone Palmitate Long-Acting Injection Downstream Customers
Table 105. Paliperidone Palmitate Long-Acting Injection Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Paliperidone Palmitate Long-Acting Injection Product Picture
Figure 2. Global Paliperidone Palmitate Long-Acting Injection Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 4. Global Paliperidone Palmitate Long-Acting Injection Sales Volume (K Dose), 2021–2032
Figure 5. Global Paliperidone Palmitate Long-Acting Injection Sales Price (US$/Dose), 2021–2032
Figure 6. Paliperidone Palmitate Long-Acting Injection Report Years Considered
Figure 7. Global Paliperidone Palmitate Long-Acting Injection Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Paliperidone Palmitate Long-Acting Injection Sales Volume Ranking of Players (K Dose), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Paliperidone Palmitate Long-Acting Injection Revenue in 2025
Figure 10. Paliperidone Palmitate Long-Acting Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Monthly Dosage Form Picture
Figure 12. Quarterly Dosage Form Picture
Figure 13. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Paliperidone Palmitate Long-Acting Injection Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Type (K Dose), 2021 vs 2025 vs 2032
Figure 16. Global Paliperidone Palmitate Long-Acting Injection Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global Paliperidone Palmitate Long-Acting Injection Price by Type (US$/Dose), 2021–2032
Figure 18. Product Picture of General Hospital
Figure 19. Product Picture of Specialized Hospital
Figure 20. Product Picture of Others
Figure 21. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Paliperidone Palmitate Long-Acting Injection Sales Value Market Share by Application, 2025 & 2032
Figure 23. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Application (K Dose), 2021 vs 2025 vs 2032
Figure 24. Global Paliperidone Palmitate Long-Acting Injection Sales Volume Market Share by Application, 2025 & 2032
Figure 25. Global Paliperidone Palmitate Long-Acting Injection Price by Application (US$/Dose), 2021–2032
Figure 26. North America Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 27. North America Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2025 vs 2032
Figure 28. Europe Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 29. Europe Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2025 vs 2032
Figure 30. Asia Pacific Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 31. Asia Pacific Paliperidone Palmitate Long-Acting Injection Sales Value by Region (%), 2025 vs 2032
Figure 32. South America Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 33. South America Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2025 vs 2032
Figure 34. Middle East & Africa Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 35. Middle East & Africa Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2025 vs 2032
Figure 36. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value (%), 2021–2032
Figure 37. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Volume (%), 2021–2032
Figure 38. United States Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 39. United States Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
Figure 40. United States Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2025 vs 2032
Figure 41. Europe Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 42. Europe Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
Figure 43. Europe Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2025 vs 2032
Figure 44. China Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 45. China Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
Figure 46. China Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2025 vs 2032
Figure 47. Japan Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 48. Japan Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
Figure 49. Japan Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2025 vs 2032
Figure 50. South Korea Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 51. South Korea Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
Figure 52. South Korea Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2025 vs 2032
Figure 53. Southeast Asia Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 54. Southeast Asia Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
Figure 55. Southeast Asia Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2025 vs 2032
Figure 56. India Paliperidone Palmitate Long-Acting Injection Sales Value (US$ Million), 2021–2032
Figure 57. India Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2025 vs 2032
Figure 58. India Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2025 vs 2032
Figure 59. Paliperidone Palmitate Long-Acting Injection Industrial Chain
Figure 60. Paliperidone Palmitate Long-Acting Injection Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Related Reports
Global Paliperidone Palmitate Long-Acting Injection Market Insights, Forecast to 2031
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6283 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
Published Date: 2025-04-25
Pages: 141
USD 4900.00
(Single User License)
Paliperidone Palmitate Long-Acting Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-04-25
Pages: 95
USD 3950.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-04-25
Pages: 80
USD 4250.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2025
The global market for Paliperidone Palmitate Long-Acting Injection was valued at US$ 4115 million in the year 2024 and is projected to reach a revised size of US$ 6283 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-04-25
Pages: 83
USD 2900.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4355 million in 2025 and is forecast to reach a readjusted size of US$ 6640 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 80
USD 4250.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2026
The global Paliperidone Palmitate Long-Acting Injection market was valued at US$ 4355 million in 2025 and is anticipated to reach US$ 6640 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 110
USD 2900.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6640 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 147
USD 4900.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Insights, Forecast to 2031
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6283 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
Published: 2025-04-25
Pages: 141
USD 4900.00 (Single User License)Paliperidone Palmitate Long-Acting Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-04-25
Pages: 95
USD 3950.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-04-25
Pages: 80
USD 4250.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2025
The global market for Paliperidone Palmitate Long-Acting Injection was valued at US$ 4115 million in the year 2024 and is projected to reach a revised size of US$ 6283 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-04-25
Pages: 83
USD 2900.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4355 million in 2025 and is forecast to reach a readjusted size of US$ 6640 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 80
USD 4250.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2026
The global Paliperidone Palmitate Long-Acting Injection market was valued at US$ 4355 million in 2025 and is anticipated to reach US$ 6640 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-03-11
Pages: 110
USD 2900.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6640 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 147
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research